Home LiteratureArticle Details
PMID: 17371945 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Activation-induced expression of CD137 permits detection, isolation, and expansion of the full repertoire of CD8+ T cells responding to antigen without requiring knowledge of epitope specificities.

Blood ·Vol. 110 ·No. 1 ·2007-07-01 ·Pages 201-10

Wolfl M, Kuball J, Ho WY, Nguyen H, Manley TJ, Bleakley M, Greenberg PD

Abstract

CD137 is a member of the TNFR-family with costimulatory function. Here we show that it also has many favorable characteristics as a surrogate marker for antigen-specific activation of human CD8(+) T cells. Although undetectable on unstimulated CD8(+) T cells, it is uniformly up-regulated 24 hours after stimulation on virtually all responding cells regardless of differentiation stage or profile of cytokine secretion, which circumvents limitations of current surrogate markers for defining the repertoire of responding cells based on only individual functions. Antibody-labeled responding CD137(+) cells can be easily and efficiently isolated by flow sorting or magnetic beads to substantially enrich antigen-specific T cells. To test this approach for epitope discovery, we examined in vitro priming of naive T cells from healthy donors to Wilms tumor antigen 1 (WT1), a protein overexpressed in various malignancies. Two overlapping pentadecamers were identified as immunogenic, and further analysis defined WT1((286-293)) as the minimal amino acid sequence and HLA-Cw07 as the HLA restriction element. In conclusion, this approach appears to be an efficient and sensitive in vitro technique to rapidly identify and isolate antigen-specific CD8(+) T cells present at low frequencies and displaying heterogeneous functional profiles, and does not require prior knowledge of the specific epitopes recognized or the HLA-restricting elements.

MeSH Terms
CD8-Positive T-Lymphocytes/cytology,immunology Cell Culture Techniques Cell Proliferation Cell Separation Epitopes, T-Lymphocyte Humans Immunomagnetic Separation/methods Lymphocyte Activation T-Cell Antigen Receptor Specificity Tumor Necrosis Factor Receptor Superfamily, Member 9/biosynthesis Up-Regulation WT1 Proteins/immunology
Chemicals
Epitopes, T-Lymphocyte Tumor Necrosis Factor Receptor Superfamily, Member 9 WT1 Proteins
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Wolfl Matthias
Fred Hutchinson Cancer Research Center, Program in Immunology, Seattle, WA, USA. [email protected]
Kuball Jürgen
Ho William Y
Nguyen Hieu
Manley Thomas J
Bleakley Marie
Greenberg Philip D
References (43)
43 references, click to expand
  1. SYFPEITHI: database for MHC ligands and peptide motifs.
    Immunogenetics. 1999 Nov;50(3-4):213-9 PMID: 10602881
  2. Phenotypic analysis of antigen-specific T lymphocytes.
    Science. 1996 Oct 4;274(5284):94-6 PMID: 8810254
  3. Analysis of CD8 T cell reactivity to cytomegalovirus using protein-spanning pools of overlapping pentadecapeptides.
    Eur J Immunol. 2000 Jun;30(6):1676-82 PMID: 10898504
  4. Ex vivo IFN-gamma secretion by circulating CD8 T lymphocytes: implications of a novel approach for T cell monitoring in infectious and malignant diseases.
    J Immunol. 2001 Jun 15;166(12):7634-40 PMID: 11390521
  5. 4-1BB ligand induces cell division, sustains survival, and enhances effector function of CD4 and CD8 T cells with similar efficacy.
    J Immunol. 2001 Aug 1;167(3):1313-24 PMID: 11466348
  6. Functions of CD8 T-cell subsets secreting different cytokine patterns.
    Semin Immunol. 1997 Apr;9(2):87-92 PMID: 9194219
  7. T-cell epitope mapping by flow cytometry.
    Nat Med. 1998 Aug;4(8):975-8 PMID: 9701254
  8. Role of 4-1BB in immune responses.
    Semin Immunol. 1998 Dec;10(6):481-9 PMID: 9826581
  9. High frequencies of naive Melan-A/MART-1-specific CD8(+) T cells in a large proportion of human histocompatibility leukocyte antigen (HLA)-A2 individuals.
    J Exp Med. 1999 Sep 6;190(5):705-15 PMID: 10477554
  10. TNF/TNFR family members in costimulation of T cell responses.
    Annu Rev Immunol. 2005;23:23-68 PMID: 15771565
  11. Generation of CMV-specific T lymphocytes using protein-spanning pools of pp65-derived overlapping pentadecapeptides for adoptive immunotherapy.
    Blood. 2005 Apr 1;105(7):2793-801 PMID: 15514011
  12. Acquisition of full effector function in vitro paradoxically impairs the in vivo antitumor efficacy of adoptively transferred CD8+ T cells.
    J Clin Invest. 2005 Jun;115(6):1616-26 PMID: 15931392
  13. Cellular immune selection with hepatitis C virus persistence in humans.
    J Exp Med. 2005 Jun 6;201(11):1741-52 PMID: 15939790
  14. Wilms' tumour gene 1 (WT1) in human neoplasia.
    Leukemia. 2005 Aug;19(8):1318-23 PMID: 15920488
  15. Measuring Ag-specific immune responses: understanding immunopathogenesis and improving diagnostics in infectious disease, autoimmunity and cancer.
    Trends Immunol. 2005 Sep;26(9):477-84 PMID: 16039158
  16. A live-cell assay to detect antigen-specific CD4+ T cells with diverse cytokine profiles.
    Nat Med. 2005 Oct;11(10):1113-7 PMID: 16186817
  17. Direct access to CD4+ T cells specific for defined antigens according to CD154 expression.
    Nat Med. 2005 Oct;11(10):1118-24 PMID: 16186818
  18. Antigen-specific cellular immunotherapy of leukemia.
    Leukemia. 2005 Nov;19(11):1863-71 PMID: 16121214
  19. IL-15-dependent induction of 4-1BB promotes antigen-independent CD8 memory T cell survival.
    J Immunol. 2006 Mar 1;176(5):2739-48 PMID: 16493029
  20. In vitro methods for generating CD8+ T-cell clones for immunotherapy from the naïve repertoire.
    J Immunol Methods. 2006 Mar 20;310(1-2):40-52 PMID: 16469329
  21. Toll-like receptor agonists influence the magnitude and quality of memory T cell responses after prime-boost immunization in nonhuman primates.
    J Exp Med. 2006 May 15;203(5):1249-58 PMID: 16636134
  22. Targeting the activation-induced antigen CD137 can selectively deplete alloreactive T cells from antileukemic and antitumor donor T-cell lines.
    Blood. 2007 Jan 1;109(1):365-73 PMID: 16931626
  23. Identification of a novel WT1-derived peptide which induces human leucocyte antigen-A24-restricted anti-leukaemia cytotoxic T lymphocytes.
    Br J Haematol. 2002 Mar;116(3):601-3 PMID: 11849218
  24. 4-1BB ligand-mediated costimulation of human T cells induces CD4 and CD8 T cell expansion, cytokine production, and the development of cytolytic effector function.
    J Immunol. 2002 May 15;168(10):4897-906 PMID: 11994439
  25. 4-1BB promotes the survival of CD8+ T lymphocytes by increasing expression of Bcl-xL and Bfl-1.
    J Immunol. 2002 Nov 1;169(9):4882-8 PMID: 12391199
  26. Two distinct HLA-A0201-presented epitopes of the Wilms tumor antigen 1 can function as targets for leukemia-reactive CTL.
    Blood. 2002 Nov 15;100(10):3835-7 PMID: 12411326
  27. Towards patient-specific tumor antigen selection for vaccination.
    Immunol Rev. 2002 Oct;188:164-76 PMID: 12445290
  28. Adoptive immunotherapy: engineering T cell responses as biologic weapons for tumor mass destruction.
    Cancer Cell. 2003 May;3(5):431-7 PMID: 12781360
  29. Ex vivo characterization of human CD8+ T subsets with distinct replicative history and partial effector functions.
    Blood. 2003 Sep 1;102(5):1779-87 PMID: 12750165
  30. Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation.
    J Immunol Methods. 2003 Oct 1;281(1-2):65-78 PMID: 14580882
  31. Human CD8(+) T-cell differentiation in response to viruses.
    Nat Rev Immunol. 2003 Dec;3(12):931-9 PMID: 14647475
  32. Persistent recognition of autologous virus by high-avidity CD8 T cells in chronic, progressive human immunodeficiency virus type 1 infection.
    J Virol. 2004 Jan;78(2):630-41 PMID: 14694094
  33. Expression and function of 4-1BB during CD4 versus CD8 T cell responses in vivo.
    Eur J Immunol. 2004 Mar;34(3):743-51 PMID: 14991604
  34. Central memory and effector memory T cell subsets: function, generation, and maintenance.
    Annu Rev Immunol. 2004;22:745-63 PMID: 15032595
  35. Random screening of proteins for HLA-A*0201-binding nine-amino acid peptides is not sufficient for identifying CD8 T cell epitopes recognized in the context of HLA-A*0201.
    J Immunol. 2004 Jun 1;172(11):6783-9 PMID: 15153496
  36. Blockade of 4-1BB (CD137)/4-1BB ligand interactions increases allograft survival.
    Transpl Int. 2004 Aug;17(7):351-61 PMID: 15349720
  37. Cancer regression in patients with metastatic melanoma after the transfer of autologous antitumor lymphocytes.
    Proc Natl Acad Sci U S A. 2004 Oct 5;101 Suppl 2:14639-45 PMID: 15381769
  38. cDNA sequences of two inducible T-cell genes.
    Proc Natl Acad Sci U S A. 1989 Mar;86(6):1963-7 PMID: 2784565
  39. Detection of intracellular cytokines by flow cytometry.
    J Immunol Methods. 1993 Feb 26;159(1-2):197-207 PMID: 8445253
  40. Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains.
    J Immunol. 1994 Jan 1;152(1):163-75 PMID: 8254189
  41. Allele-specific peptide ligand motifs of HLA-C molecules.
    Proc Natl Acad Sci U S A. 1993 Dec 15;90(24):12005-9 PMID: 8265661
  42. Analysis and sorting of live cells according to secreted molecules, relocated to a cell-surface affinity matrix.
    Proc Natl Acad Sci U S A. 1995 Mar 14;92(6):1921-5 PMID: 7892200
  43. Human cytotoxic T-lymphocyte responses specific for peptides of the wild-type Wilms' tumor gene (WT1 ) product.
    Immunogenetics. 2000 Feb;51(2):99-107 PMID: 10663572
Article Info
Journal
Blood
Abbr.
Blood
ISSN
0006-4971
Published
2007-07-01
Epub
2007-00-19
Pages
201-10
Language
English
Region
United States
NLM ID
7603509
PMCID
PMC1896114
Subset
IM
Grants
NCI NIH HHS · P01 CA018029 · United States
NCI NIH HHS · R37 CA033084 · United States
NCI NIH HHS · P01 CA18029 · United States
NCI NIH HHS · R37 CA33084 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]